New blood tests for multiple cancers gain political backing
Dec. 2 (UPI) — As a new blood tests capable of detecting dozens of cancers in their early…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal
Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…
Health-Care Earnings Top S&P 500 on Strong Drug, Hospital Demand
The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty…
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?
Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
FDA Unveils New Path for Approving Drugs for Just One Patient
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring…
FDA’s plan to boost cheaper copycat drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis,…
Vitamin D in tailored doses found to reduce heart attack risk
Vitamin D might help people with heart disease avoid a heart attack, if it’s provided in a dose…
580K bottles of blood pressure medications recalled due to cancer-causing chemical – WSB-TV Channel 2
More than half a million bottles of a popular blood pressure medication have been recalled because they contain…
FDA announces plans to relax rules about copycat drugs
The U.S. Food and Drug Administration announced Wednesday that it will relax certain rules for approving low-cost versions…
FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the…